192 related articles for article (PubMed ID: 36525819)
1. Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Biomed Pharmacother; 2023 Feb; 158():114132. PubMed ID: 36525819
[TBL] [Abstract][Full Text] [Related]
2. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
3. Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria.
Teramura T; Mizuno M; Asano H; Naru E; Kawara S; Kamide R; Kawada A
J Dermatol; 2018 Feb; 45(2):145-149. PubMed ID: 29266358
[TBL] [Abstract][Full Text] [Related]
4. Cimetidine for erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102793. PubMed ID: 35245673
[TBL] [Abstract][Full Text] [Related]
5. Phototesting in erythropoietic protoporphyria trials: A systematic review.
Heerfordt IM; Philipsen PA; Lerche CM; Wulf HC
Exp Dermatol; 2023 Jul; 32(7):1042-1047. PubMed ID: 37052136
[TBL] [Abstract][Full Text] [Related]
6. Protection against visible light by dihydroxyacetone in erythropoietic protoporphyria.
Heerfordt IM; Philipsen PA; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103302. PubMed ID: 36690194
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria.
Balwani M; Naik H; Overbey JR; Bonkovsky HL; Bissell DM; Wang B; Phillips JD; Desnick RJ; Anderson KE
Mol Genet Metab Rep; 2022 Dec; 33():100939. PubMed ID: 36406817
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria.
Minder EI; Schneider-Yin X; Steurer J; Bachmann LM
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):84-97. PubMed ID: 19268006
[TBL] [Abstract][Full Text] [Related]
9. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
[TBL] [Abstract][Full Text] [Related]
10. Acquired erythropoietic protoporphyria: A systematic review of the literature.
Snast I; Kaftory R; Sherman S; Edel Y; Hodak E; Levi A; Lapidoth M
Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):29-33. PubMed ID: 31374130
[TBL] [Abstract][Full Text] [Related]
11. Phototolerance induced by narrow-band UVB phototherapy in severe erythropoietic protoporphyria.
García-Martín P; De Argila D; To-Figueras J; Llamas-Velasco M; Fraga J; García-Diez A
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):261-3. PubMed ID: 22971192
[TBL] [Abstract][Full Text] [Related]
12. Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria.
Alemzadeh R; Feehan T
Eur J Pediatr; 2004 Sep; 163(9):547-9. PubMed ID: 15241683
[TBL] [Abstract][Full Text] [Related]
13. Dersimelagon in Erythropoietic Protoporphyrias.
Balwani M; Bonkovsky HL; Levy C; Anderson KE; Bissell DM; Parker C; Takahashi F; Desnick RJ; Belongie K;
N Engl J Med; 2023 Apr; 388(15):1376-1385. PubMed ID: 37043653
[TBL] [Abstract][Full Text] [Related]
14. Effects of iron supplements in individuals with erythropoietic protoporphyria.
Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC
Photodiagnosis Photodyn Ther; 2024 Jun; 47():104211. PubMed ID: 38734198
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
16. Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming.
Heerfordt IM; Heydenreich J; Philipsen PA; Lerche CM; Wulf HC
J Photochem Photobiol B; 2020 Dec; 213():112054. PubMed ID: 33075648
[TBL] [Abstract][Full Text] [Related]
17. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.
Minder AE; Barman-Aksoezen J; Schmid M; Minder EI; Zulewski H; Minder CE; Schneider-Yin X
Ther Adv Rare Dis; 2021; 2():26330040211065453. PubMed ID: 37181106
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietic protoporphyria: case reports for clinical and therapeutic hints.
Tumminelli C; Burlo F; Pastore S; Severini GM; Berti I; Marchini S; Zanon D; De Martino E; Tommasini A
Ital J Pediatr; 2023 Nov; 49(1):156. PubMed ID: 37996925
[TBL] [Abstract][Full Text] [Related]
19. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of erythropoietic protoporphyria - role of afamelanotide.
Lane AM; McKay JT; Bonkovsky HL
Appl Clin Genet; 2016; 9():179-189. PubMed ID: 28003770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
